Associations of circulating metabolites with cerebral white matter hyperintensities
暂无分享,去创建一个
L. Tan | Hong-Qi Li | Jin Yu | Yan Sun | Yu Guo | W. Cheng | Jianfeng Feng
[1] T. Lehtimäki,et al. Glycoprotein Acetyls: A Novel Inflammatory Biomarker of Early Cardiovascular Risk in the Young , 2022, Journal of the American Heart Association.
[2] M. Kroh,et al. The Effect of Bariatric Surgery on Circulating Levels of Oxidized Low-Density Lipoproteins Is Apparently Independent of Changes in Body Mass Index: A Systematic Review and Meta-Analysis , 2021, Oxidative medicine and cellular longevity.
[3] K. Wartolowska,et al. Blood Pressure Determinants of Cerebral White Matter Hyperintensities and Microstructural Injury: UK Biobank Cohort Study , 2021, Hypertension.
[4] K. Wartolowska,et al. Midlife blood pressure is associated with the severity of white matter hyperintensities: analysis of the UK Biobank cohort study , 2020, European heart journal.
[5] C. Dyck,et al. Alzheimer's & Dementia: The Journal of the Alzheimer's Association , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[6] W. M. van der Flier,et al. Circulating metabolites are associated with brain atrophy and white matter hyperintensities , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[7] T. Paus,et al. Thickness of the cerebral cortex shows positive association with blood levels of triacylglycerols carrying 18-carbon fatty acids , 2020, Communications Biology.
[8] A. Hainsworth,et al. Association of White Matter Hyperintensities and Cardiovascular Disease , 2020, Circulation. Cardiovascular imaging.
[9] M. Dichgans,et al. Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol. , 2020, Brain : a journal of neurology.
[10] T. Paus,et al. A variant near DHCR24 associates with microstructural properties of white matter and peripheral lipid metabolism in adolescents , 2020, Molecular Psychiatry.
[11] B. Nordestgaard,et al. Impact of LDL Cholesterol on Microvascular Versus Macrovascular Disease: A Mendelian Randomization Study. , 2019, Journal of the American College of Cardiology.
[12] C. Jack,et al. Cardiometabolic Health and Longitudinal Progression of White Matter Hyperintensity: The Mayo Clinic Study of Aging. , 2019, Stroke.
[13] M. Dichgans,et al. Small vessel disease: mechanisms and clinical implications , 2019, The Lancet Neurology.
[14] C. Jack,et al. Plasma Metabolites Associated with Brain MRI Measures of Neurodegeneration in Older Adults in the Atherosclerosis Risk in Communities–Neurocognitive Study (ARIC-NCS) , 2019, International journal of molecular sciences.
[15] N. Stachenfeld,et al. Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan. , 2018, American journal of physiology. Heart and circulatory physiology.
[16] T. Paus,et al. Visceral fat-related systemic inflammation and the adolescent brain: a mediating role of circulating glycerophosphocholines , 2018, International Journal of Obesity.
[17] V. Salomaa,et al. Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer’s disease: A prospective study in eight cohorts , 2018, Alzheimer's & Dementia.
[18] Kenneth J. Smith,et al. Understanding a role for hypoxia in lesion formation and location in the deep and periventricular white matter in small vessel disease and multiple sclerosis. , 2017, Clinical science.
[19] Michael W. Weiner,et al. Metabolic network failures in Alzheimer's disease: A biochemical road map , 2017, Alzheimer's & Dementia.
[20] Cathie Sudlow,et al. UK Biobank: opportunities for cardiovascular research , 2017, European heart journal.
[21] Debbie A Lawlor,et al. Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies , 2017, American journal of epidemiology.
[22] Ludovica Griffanti,et al. Image processing and Quality Control for the first 10,000 brain imaging datasets from UK Biobank , 2017, NeuroImage.
[23] Paul M. Thompson,et al. Cerebral amyloid is associated with greater white-matter hyperintensity accrual in cognitively normal older adults , 2016, Neurobiology of Aging.
[24] P. Matthews,et al. Multimodal population brain imaging in the UK Biobank prospective epidemiological study , 2016, Nature Neuroscience.
[25] Tom R. Gaunt,et al. Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. , 2015, Circulation.
[26] P. Elliott,et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.
[27] Pasi Soininen,et al. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. , 2015, Circulation. Cardiovascular genetics.
[28] Carole Dufouil,et al. Plasma lipids and cerebral small vessel disease , 2014, Neurology.
[29] D. Rader,et al. HDL and cardiovascular disease , 2014, The Lancet.
[30] N. Paynter,et al. High-Density Lipoprotein Particle Subclass Heterogeneity and Incident Coronary Heart Disease , 2014, Circulation. Cardiovascular quality and outcomes.
[31] Victoria J. Williams,et al. Interindividual variation in serum cholesterol is associated with regional white matter tissue integrity in older adults , 2013, Human brain mapping.
[32] Nick C Fox,et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.
[33] A. Kontush,et al. Biological activities of HDL subpopulations and their relevance to cardiovascular disease. , 2011, Trends in molecular medicine.
[34] R. Skoff,et al. Sexual dimorphism in the white matter of rodents , 2009, Journal of the Neurological Sciences.
[35] M. van Buchem,et al. Different progression rates for deep white matter hyperintensities in elderly men and women , 2004, Neurology.
[36] R. Krauss,et al. Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins. , 2001, The American journal of medicine.
[37] M. Maletic-Savatic,et al. Metabolomics of neurodegenerative diseases. , 2015, International review of neurobiology.